CD8A and neoplasm: As Tregs in the tumor microenvironment are key to regulating CD8+T cells-mediated tumor rejection (23), we also investigated the suppression ability of GO-Y022-treated Tregs co-cultured with CellTraceTM Violet -labeled responder cells (CD8+ T cells).